About
Linda Goodman is a co-founder and CTO of Fauna Bio, a biotechnology company using animal genomics and AI to discover therapeutics for human disease. Fauna Bio says she earned an MPhil in Computational Biology from the University of Cambridge and a Ph.D. in Genetics and Genomics from Harvard University, and previously worked at the Broad Institute and Stanford University. Her public profile is that of a scientist-founder focused on comparative mammalian genomics, translational biology, and age-related disease research.
Areas of interest
longevitybiotechgenomicscomparative genomicscomputational biologyAI drug discoverycardiometabolic diseasefibrosisobesityneurodegenerative diseasehibernation biologyevolutionary biology